Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001968202-24-000084 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-05 | 2024-03-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $982.05 | -100 | 18.4K | -0.5% | -$98.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | S | D | 4 | $987.33 | 18,283 | D | — | — | (F9) Represents volume-weighted average price of sales of 4 shares of Company stock on March 1, 2024 at prices ranging from $987.05 to $987.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price. |
| 2 | Common | Common Stock | 2024-03-01 | S | D | 8 | $986.58 | 18,287 | D | — | — | (F8) Represents volume-weighted average price of sales of 8 shares of Company stock on March 1, 2024 at prices ranging from $986.45 to $986.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price. |
| 3 | Common | Common Stock | 2024-03-01 | S | D | 10 | $985.76 | 18,295 | D | — | — | (F7) Represents volume-weighted average price of sales of 10 shares of Company stock on March 1, 2024 at prices ranging from $985.26 to $985.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price. |
| 4 | Common | Common Stock | 2024-03-01 | S | D | 19 | $984.45 | 18,305 | D | — | — | (F6) Represents volume-weighted average price of sales of 19 shares of Company stock on March 1, 2024 at prices ranging from $984.00 to $984.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price. |
| 5 | Common | Common Stock | 2024-03-01 | S | D | 1 | $971.75 | 18,374 | D | — | — | |
| 6 | Common | Common Stock | 2024-03-01 | S | D | 1 | $988.30 | 18,282 | D | — | — | |
| 7 | Common | Common Stock | 2024-03-01 | S | D | 12 | $983.61 | 18,324 | D | — | — | (F5) Represents volume-weighted average price of sales of 12 shares of Company stock on March 1, 2024 at prices ranging from $983.21 to $983.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price. |
| 8 | Common | Common Stock | 2024-03-01 | S | D | 11 | $982.67 | 18,336 | D | — | — | (F4) Represents volume-weighted average price of sales of 11 shares of Company stock on March 1, 2024 at prices ranging from $982.51 to $982.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price. |
| 9 | Common | Common Stock | 2024-03-01 | S | D | 15 | $981.64 | 18,347 | D | — | — | (F3) Represents volume-weighted average price of sales of 15 shares of Company stock on March 1, 2024 at prices ranging from $981.09 to $981.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price. |
| 10 | Common | Common Stock | 2024-03-01 | S | D | 1 | $980.21 | 18,362 | D | — | — | |
| 11 | Common | Common Stock | 2024-03-01 | S | D | 1 | $979.87 | 18,363 | D | — | — | |
| 12 | Common | Common Stock | 2024-03-01 | S | D | 1 | $978.09 | 18,364 | D | — | — | |
| 13 | Common | Common Stock | 2024-03-01 | S | D | 2 | $977.27 | 18,365 | D | — | — | (F2) Represents volume-weighted average price of sales of 2 shares of Company stock on March 1, 2024 at prices ranging from $977.00 to $977.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2024 at each separate price. |
| 14 | Common | Common Stock | 2024-03-01 | S | D | 2 | $976.81 | 18,367 | D | — | — | |
| 15 | Common | Common Stock | 2024-03-01 | S | D | 2 | $975.70 | 18,369 | D | — | — | |
| 16 | Common | Common Stock | 2024-03-01 | S | D | 1 | $974.78 | 18,371 | D | — | — | |
| 17 | Common | Common Stock | 2024-03-01 | S | D | 2 | $972.29 | 18,372 | D | — | — | |
| 18 | Common | Common Stock | 2024-03-01 | S | D | 1 | $967.50 | 18,381 | D | — | — | |
| 19 | Common | Common Stock | 2024-03-01 | S | D | 1 | $968.66 | 18,380 | D | — | — | |
| 20 | Common | Common Stock | 2024-03-01 | S | D | 1 | $969.18 | 18,379 | D | — | — | |
| 21 | Common | Common Stock | 2024-03-01 | S | D | 4 | $970.38 | 18,375 | D | — | — |